DNA [NYSE]
Ginkgo Bioworks Holdings, Inc.
Index- P/E- EPS (ttm)-1.22 Insider Own0.40% Shs Outstand1.53B Perf Week-1.88%
Market Cap3.47B Forward P/E- EPS next Y-0.13 Insider Trans0.00% Shs Float856.36M Perf Month-24.35%
Income-1830.00M PEG- EPS next Q-0.03 Inst Own77.40% Short Float10.80% Perf Quarter-43.87%
Sales313.80M P/S11.07 EPS this Y- Inst Trans- Short Ratio4.38 Perf Half Y-78.21%
Book/sh0.98 P/B2.66 EPS next Y31.20% ROA-95.40% Target Price9.14 Perf Year-73.61%
Cash/sh1.16 P/C2.24 EPS next 5Y- ROE-119.90% 52W Range2.09 - 15.86 Perf YTD-68.59%
Dividend- P/FCF- EPS past 5Y- ROI-119.60% 52W High-83.55% Beta-
Dividend %- Quick Ratio12.80 Sales past 5Y- Gross Margin71.70% 52W Low24.88% ATR0.36
Employees641 Current Ratio12.80 Sales Q/Q483.40% Oper. Margin- RSI (14)43.80 Volatility13.30% 13.82%
OptionableYes Debt/Eq0.01 EPS Q/Q- Profit Margin- Rel Volume1.18 Prev Close2.52
ShortableYes LT Debt/Eq0.01 EarningsMay 16 AMC Payout- Avg Volume21.13M Price2.61
Recom1.50 SMA20-9.77% SMA50-20.47% SMA200-67.22% Volume24,984,255 Change3.57%
May-18-22Downgrade BofA Securities Neutral → Underperform $3
Mar-02-22Resumed Cowen Outperform $12
Feb-23-22Initiated Goldman Neutral $7
Feb-01-22Initiated BofA Securities Neutral $6
Jan-28-22Initiated BofA Securities Buy $8
Jan-07-22Initiated BTIG Research Buy $12
Nov-29-21Initiated Jefferies Buy $16
Oct-13-21Initiated Raymond James Outperform $14.50
Oct-12-21Initiated William Blair Outperform
Sep-20-21Initiated HSBC Securities Buy $14
May-18-22 07:00AM  
May-16-22 04:01PM  
May-14-22 09:59AM  
May-11-22 07:00AM  
May-10-22 01:55PM  
May-09-22 07:00AM  
May-04-22 02:22PM  
Apr-22-22 04:41PM  
08:00AM  
Apr-14-22 05:00PM  
Apr-13-22 07:00AM  
Apr-12-22 07:00AM  
Apr-11-22 07:00AM  
Apr-05-22 07:00AM  
Apr-04-22 05:00PM  
07:00AM  
Mar-30-22 02:26PM  
Mar-29-22 02:14PM  
Mar-28-22 04:01PM  
Mar-23-22 07:00AM  
Mar-22-22 02:19PM  
Mar-17-22 08:15AM  
Mar-15-22 07:00AM  
Mar-14-22 07:00AM  
Mar-04-22 05:00AM  
Feb-28-22 04:00AM  
Feb-24-22 07:00AM  
Feb-18-22 07:30AM  
Feb-08-22 04:00PM  
Jan-19-22 07:00AM  
Jan-18-22 09:38AM  
09:38AM  
Jan-14-22 01:38PM  
Jan-12-22 07:00AM  
Jan-11-22 11:21AM  
Jan-10-22 08:00AM  
07:00AM  
07:00AM  
Jan-06-22 01:50PM  
07:00AM  
Jan-05-22 07:00AM  
Dec-31-21 07:35PM  
03:40PM  
02:35PM  
11:00AM  
Dec-30-21 07:37PM  
03:40PM  
02:56PM  
11:00AM  
09:00AM  
Dec-29-21 11:47PM  
03:00PM  
08:45AM  
Dec-28-21 08:44PM  
03:40PM  
01:00PM  
08:45AM  
Dec-27-21 04:00PM  
02:04PM  
09:55AM  
08:32AM  
Dec-24-21 11:00AM  
10:15AM  
01:38AM  
01:38AM  
Dec-23-21 09:07PM  
08:26PM  
05:00PM  
01:30PM  
08:40AM  
06:35AM  
Dec-22-21 04:45PM  
08:40AM  
Dec-21-21 10:31PM  
07:05PM  
03:30PM  
10:02AM  
08:45AM  
Dec-20-21 09:40AM  
08:45AM  
07:00AM  
Dec-19-21 09:00PM  
08:48PM  
08:44PM  
Dec-18-21 12:33AM  
Dec-17-21 04:00PM  
12:05PM  
09:27AM  
08:45AM  
08:43AM  
Dec-16-21 05:18PM  
04:00PM  
04:00PM  
09:55AM  
08:40AM  
Dec-15-21 05:44PM  
02:00PM  
09:28AM  
Dec-14-21 09:00PM  
05:14PM  
Ginkgo Bioworks Holdings, Inc. develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agriculture, food, consumer products, and pharmaceuticals. Ginkgo Bioworks has a partnership with Selecta Biosciences, Inc. to advance treatments for orphan and rare diseases. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is based in Boston, Massachusetts.